Title: Comparison of Outcomes of ACS in Prediabetes and Nondiabetic In a Tertiary Care Centre

Authors: S Thrudeep, G Rajesh, T G Jayakumar, G Rupesh, G K Geofi, S Gagan,  S Abdulkhadhar

 DOI:  http://dx.doi.org/10.18535/jmscr/v4i6.66

Abstract

Background: Pre diabetes is a definite risk factor in cases of STEMI. This study was aimed to compare various clinical outcomes, coronary angiographic results and incidence of major adverse cardiovascular event (MACE) in prediabetic patients presented with STEMI with those of non prediabetic STEMI patients in a tertiary care centre.

Methods: Study was conducted in prediabetic patients presented with STEMI whose fasting serum glucose and glycated hemoglobin level were 100-125 mg/dl and 5.7-6.4%, were respectively. Age and sex matched non prediabetic patients with STEMI was selected as control group. Demographic variables were taken. Further the clinical presentations; findings of coronary angiogram; electrocardiogram (ECG) and 2D echo; morbidity and cardiac mortality were collected and subjected to statistical analysis.

Results: Total of 70 patients (35 prediabetic and 35 non prediabetic control) with ACS STEMI were included in the prospective study. The prediabetic patients with ACS STEMI were found with clinical presentation (Killip class III and IV); ECG manifestations (Tachyarrythmia); 2 D echo (Moderate and severe left ventricular dysfunction); angiographic findings (Double and Triple vessel disease, Right coronary artery(RCA), Left circumflex artery (LCX), Long Stents); morbidity (MACE and site hematoma) and cardiac mortality more than the non prediabetic control group.

Conclusion: The results showed that prediabetic group had higher Killip class, more multivessel disease, higher MACE and cardiovascular mortality as compared to control group.

References

    

1.      D.Mukherjee et al; Impact of  Prediabetic state on clinical outcome s in patients with ACS:Heart 2005,91:1466-1468

2.      Mohan V  et al. Epidemology of Type 2 Diabetes : Indian Scenario.Indian J Med Res.Mar 2007;125(3):217-230

3.      Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospe-ctive study. Lancet 2002;359:2140–4.

4.      American diabetes association : Standards of medical care in diabetes .Diabetic care,2011,34:S11

5.      Loscaloz et al Diabetes  introduction . Principles of Internal Medicine Harrison 18th edition 2103,344:211

6.      Thygesen K , Alpert JS , White HD .  Universal definition of myocardial infarction .Eur Heart Journal 2007 28:2525-2538

7.      Lars Rydén, et al  ESC Guidelines 2013 on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 

8.      Kurihara O et al,Impact Of Prediabetic Status On Coronary Atherosclerosisa Multivessel Angioscopic Study in diabetes Care 2013;36:729–733

9.      Grundy SM. Pre-diabetes, metabolic syndrome,and cardiovascular risk. J Am Coll Cardiol 2012;59:635–643

10.  Ferrannini E, Gastaldelli A, Iozzo P.Pathophysiology of prediabetes.MedClin North Am 2011;95:327–339, vii–viii

11.  M. Ishihara et al.Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate forpreviously undiagnosed abnormal glucose tolerance? European Heart Journal (2006) 27, 2413–2419

12.  SThrudeep et al . Dilemma of  localization of culprit vessel by electrocardiography in acute myocardial infarction.

13.  Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor oflong-term outcome after myocardial infarction. Eur Heart J2005;25:1990–1997.

14.  Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but notimpaired fasting glucose. The Funagata diabetes Study. Diabetes Care1999;22:920–924.

15.  Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, Nawaz H.Utility of HbA(1c) levels for diabetes case finding in hospitalized patientswith hyperglycemia. Diabetes Care 2003;26:1064–1068.

16.  Oswald GA, Yudkin JS. Hyperglycemia following acute myocardialinfarction: combination of undiagnosed diabetes. Diabetic Medicine1987;4:68–70.

17.  Ishihara M et al  Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with afirst anterior wall acute myocardial infarction. Am Heart J 2003;146:674–678.

Corresponding Author

Dr Thrudeep Sagar MD

Senior Resident (DM trainee), Department of Cardiology,

Amala Institute of Medical Sciences,

Amala Nagar, Thrissur-680 555, Kerala, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile number: +919400736897